Co-op Student, Molecular Biology

About Zymeworks

zymeworks.com

Zymeworks is a royalty-driven biopharmaceutical organization developing novel medicines for patients with difficult-to-treat cancers and other serious diseases. Through proprietary antibody technology platforms, deep scientific expertise, and global partnerships, it builds and manages a portfolio of healthcare assets designed to deliver long-term impact across multiple therapeutic indications. Zymeworks advances both partnered and internal programs, including its FDA-approved product Ziihera® (zanidatamab-hrii), with a strategy centered on integrating collaborations to bring novel therapeutics to the broadest group of patients.